Dr. David A. Reichstein is a graduate of the world's premier Ocular Oncology Fellowship at Wills Eye Hospital, under the direction of Drs. Jerry and Carol Shields. Dr. Reichstein's interests include the diagnosis and management of patients with all types of ophthalmic tumors, including uveal melanoma or nevus, retinoblastoma, vitreoretinal and choroidal lymphoma, vascular tumors of the posterior segment, and choroidal metastases. He also has expertise in the management of anterior segment tumors including conjunctival melanoma, conjunctival or corneal intraepithelial neoplasia, and squamous cell carcinomas of the anterior segment. Dr. Reichstein's therapeutic expertise includes the use of topical and systemic chemotherapy, surgical management of ophthalmic tumors, and radiation using brachytherapy or external beam radiation.

Dr. Reichstein completed his ophthalmology residency at Vanderbilt Eye Institute. After completing his dedicated two-year Ocular Oncology Fellowship at Wills Eye Hospital, he then completed a two-year fellowship in Vitreoretinal Surgery at the Eye Institute of the Medical College of Wisconsin.

Dr. Reichstein has authored and co-authored numerous articles on topics in vitreoretinal surgery and ocular oncology. He has presented at major national ophthalmic meetings and maintains an active lecture schedule. He is a member of the American Academy of Ophthalmology, the American Society of Retinal Specialists, and the International Society of Ocular Oncology.

Dr. Reichstein also has surgical and clinical expertise in the management of retinal diseases including macular degeneration, diabetic retinopathy, macular surgery, and complicated retinal detachment.